Carcinoma of the Prostate: Adrenal Inhibitors

  • M. R. G. Robinson
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)


Adrenal androgens may continue to stimulate prostatic carcinoma after the suppression of testicular function by orchidectomy or oestrogen therapy. The production of adrenal androgens may be prevented by adrenalectomy, pituitary ablation or adrenal inhibitors. This paper discusses the therapeutic potential and complications of these techniques with special reference to the adrenal inhibitors.


Adrenal Cortex Plasma Testosterone Adrenal Androgen Cyproterone Acetate Testicular Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M.R.G. Robinson and B.S. Thomas, Effect of Hormone Therapy on Plasma Testosterone Levels in Prostatic Cancer, BMJ 45: 556 (1971).Google Scholar
  2. 2.
    W.B. Peeling and K. Griffiths, The Adrenal Cortex and Prostatic Cancer, Proc. Roy. Soc. Med. 67: 42 (1973).Google Scholar
  3. 3.
    R.P. Doe, P. Dickenson, H.H. Zinnerman, and U.S. Seal, Elevated Non-protein Bound Cortisol (NPD) in Pregnancy during Oestrogen Administration and in Carcinoma of the Prostate, J. Clin. Endocrinol. 29: 757 (1969).CrossRefGoogle Scholar
  4. 4.
    F. Sciarra, G. Sorcini, F. Di Silverio, and V. Gagliardi, Plasma Testosterone and Androstenediol after Orchidectomy in Prostatic Carcinoma, Clin. Endocrinol. 2: 101 (1973).CrossRefGoogle Scholar
  5. 5.
    P.C. Walsh, Physiologic Basis for Hormonal Therapy in Carcinoma of the Prostate, Urol. Clin. N. Am. 2: 125 (1975).Google Scholar
  6. 6.
    J.D. Fergusson and W.F. Hendry, Pituitary Radiation in Advanced Carcinoma of the Prostate: Analysis of 100 Cases, Br. J. Urol. 43: 514 (1971).PubMedCrossRefGoogle Scholar
  7. 7.
    A.B. Levin, R.C. Benson, and T. Nielsson, Chemical Hypophy-sectomy for Relief of Bone Pain in Carcinoma of the Prostate, J. Urol. 119: 517 (1978).PubMedGoogle Scholar
  8. 8.
    C. Huggins and W.W. Scott, Bilateral Adrenalectomy in Prostatic Cancer, Clinical Features and Urinary Excretion of 17 Keto-steroids and Oestrogen, Ann. Surg. 122: 1031 (1945).CrossRefGoogle Scholar
  9. 9.
    M.I. Resnick and J.T. Greyhack, Treatment of Stage IV Carcinoma of the Prostate, Urol. Clin. N. Am. 2: 141 (1975).Google Scholar
  10. 10.
    C.R. West and G.P. Murphy, Pituitary Ablation and Disseminated Prostatic Carcinoma, JAMA 225: 253 (1973).PubMedCrossRefGoogle Scholar
  11. 11.
    R.G. Sprague, M.H. Power, H.L. Mason, A. Albert, D.R. Mathieson, P.S. Hench, E.C. Kendall, C.H. Slocomb, and H.F. Polley, Observations on the Physiological Effect of Cortisone and ACTH in Man, Arch. Intern. Med. 85: 199 (1950).CrossRefGoogle Scholar
  12. 12.
    G.M. Muller and F. Hinman, Cortisone Treatment in Advanced Carcinoma of the Prostate, J. Urol. 72: 485 (1954).Google Scholar
  13. 13.
    J.T. Greyhack, Hormonal Treatment of Prostatic Cancer, Surg. Clin. N. Am. 39: 13 (1959).Google Scholar
  14. 14.
    J.D. Fergusson, Secondary endocrine therapy, in “Endocrine Therapy in Malignant Disease,” B.A. Stoll, ed., W.B. Saunders and Co. (1972), p. 264.Google Scholar
  15. 15.
    P.C. Walsh and P.K. Siiteri, Suppression of Plasma Androgens by Spironolactone in Castrated Men with Carcinoma of the Prostate, J. Urol. 114: 254 (1978).Google Scholar
  16. 16.
    R.N. Dexter, I.M. Fishman, R.L. Ney, and G.W. Liddle, Inhibition of Adrenal Corticosteroid synthesis by Aminoglutethimide: studies of mechanism of action, J. Clin. Endocrinol. Metab. 27: 473 (1967).PubMedCrossRefGoogle Scholar
  17. 17.
    R. Cash, A.J. Brough, M.N.P. Cohen, and P.S. Satah, Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial, J. Clin. Endocrinol. Metab. 27: 1239 (1967).PubMedCrossRefGoogle Scholar
  18. 18.
    R. Gaunt, B.G. Steinitz, and J.J. Chart, Pharmacologic alteration of steroid hormone functions, Clin. Pharmacol. Ther. 9: 657 (1968).Google Scholar
  19. 19.
    M.R.G. Robinson, R.J. Shearer, and J.D. Fergusson, Adrenal Suppression in the Treatment of Carcinoma of the Prostate, Br. J. Urol. 46: 555 (1974).PubMedCrossRefGoogle Scholar
  20. 20.
    E.J. Sanford, J.R. Drago, T.J. Rohner, R. Santon, and A. Lipton, Aminoglutethimide Medical Adrenalectomy for Advanced Prostatic Carcinoma, J. Urol. 115: 170 (1980).Google Scholar
  21. 21.
    U. Bracci, Our present procedures in the treatment of prostatic cancer, in: “Hormonal Therapy of Prostatic Cancer,” U. Bracci and F. Di Silverio, eds., COFESE, Palermo (1975), p. 177.Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • M. R. G. Robinson
    • 1
  1. 1.The General InfirmaryPontefractUK

Personalised recommendations